Is it possible to monitor the immune response on a regular frequency i.e. weekly, monthly? If the immune response is validated the question that begs to be answered, is the immune response enough to overcome
the cancer cells growth?.
this board was dead. Good to see posts. I don't know too much about the company but the technology amazes me. I buy and hold and wait. Good things happen to good companies especially in the robotic surgery field.
Yahoo loves (the streets propaganda) i.e. loves the kickback in $$. Cramer pays big time to get his messages across.
The "K" man is onto something with the BAX855 post. Here is an excerpt from baxter release, BAX 855 is based on ADVATE, a full-length FVIII molecule with more than 10 years of real-world experience. Through a collaboration with Nektar Therapeutics (NKTR), BAX 855 leverages proprietary PEGylation technology designed to extend the duration of activity of proteins in the body. This proprietary technology has been used for over 10 years in a number of approved medicines that treat chronic or serious conditions
Nktr is making moves in the right direction.
a cool investment?
what happens when commodities i.e. gold/oil goes ballistic, say 2, 3,4 years. We get years of great income and a future price of $20 pps+. I can live with that.
The question why is the enrollment taking so long? Surely there are enough women being diagnosed with breast cancer. There are 3 types of breast cancer, hormone induced, triple negative and her2 positive. Is the company being too picky or not able to identify the subset they are looking for.
As for the combo trial (Herceptin &neuvax) that should be filled quite easily.
I agree the combo of Neuvax and Herceptin offers the best chance for patients. This particular study may
provide the glue for merging roche and galena. If neuvax work by itself is one item, neuvax plus Herceptin is the real wild card in the deck and the only reason why I am still here.